Surveillance of Respiratory Pathogens among Uncontrolled Type II Diabetes Mellitus Patients
Authors/Creators
- 1. Assistant Professor, Department of Medicine, Shri M P Shah Government Medical College, Gujarat, India
Description
Background and Aim: Diabetes mellitus is a standalone risk factor for lung infections, which present with severe clinical signs, frequent complications, and increased morbidity & mortality. It has been suggested that impaired lung function and insulin resistance, type 2 diabetes, glucose intolerance, and obesity are related. The goal of the current investigation was to ascertain the relationship between LRTI in DM patients. Material and Methods: In order to research the connection between DM and lower respiratory tract infections, 200 instances of DM with lower respiratory tract infections were examined over the course of a year. Using a pre-designed organised proforma, information on each chosen patient was meticulously gathered. Based on FBS/PPBS, oral glucose tolerance, and HbA1c criteria (i.e., FBS>126 mg/dl, OGT>2oomg/dl), diabetes is diagnosed. All patients underwent Ziehl-Neelsen staining and culture-sensitivity testing. When necessary, imaging tests including computed tomography and ultrasonography were carried out. Results: The age range most frequently impacted was 40 to 59 (n=114). Males were more impacted than females, with 38% of patients hailing from urban regions and 62% from rural ones. Patients’ socioeconomic level ranged from lower socioeconomic status (48%), middle socioeconomic status (34%), to upper socioeconomic status (18%). Instances of Mycobacterium tuberculosis were most frequently isolated. Additionally, strains of Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli, and Influenza A (H1N1) were isolated. In diabetic patients, Mycobacterium tuberculosis was the most isolated organism. Dry cough from early consolidation, prior antibiotic treatment, and incorrect sputum collection are the causes of inability to detect any organism in sputum in 35% of patients. Conclusion: LRTI and other DM-related complications are more likely to develop in DM patients with age greater than 50, duration greater than 4, and uncontrolled DM status. According to radiological findings, lesions that were moderately to severely progressed and that involved both sides were more prevalent.
Abstract (English)
Background and Aim: Diabetes mellitus is a standalone risk factor for lung infections, which present with severe clinical signs, frequent complications, and increased morbidity & mortality. It has been suggested that impaired lung function and insulin resistance, type 2 diabetes, glucose intolerance, and obesity are related. The goal of the current investigation was to ascertain the relationship between LRTI in DM patients. Material and Methods: In order to research the connection between DM and lower respiratory tract infections, 200 instances of DM with lower respiratory tract infections were examined over the course of a year. Using a pre-designed organised proforma, information on each chosen patient was meticulously gathered. Based on FBS/PPBS, oral glucose tolerance, and HbA1c criteria (i.e., FBS>126 mg/dl, OGT>2oomg/dl), diabetes is diagnosed. All patients underwent Ziehl-Neelsen staining and culture-sensitivity testing. When necessary, imaging tests including computed tomography and ultrasonography were carried out. Results: The age range most frequently impacted was 40 to 59 (n=114). Males were more impacted than females, with 38% of patients hailing from urban regions and 62% from rural ones. Patients’ socioeconomic level ranged from lower socioeconomic status (48%), middle socioeconomic status (34%), to upper socioeconomic status (18%). Instances of Mycobacterium tuberculosis were most frequently isolated. Additionally, strains of Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli, and Influenza A (H1N1) were isolated. In diabetic patients, Mycobacterium tuberculosis was the most isolated organism. Dry cough from early consolidation, prior antibiotic treatment, and incorrect sputum collection are the causes of inability to detect any organism in sputum in 35% of patients. Conclusion: LRTI and other DM-related complications are more likely to develop in DM patients with age greater than 50, duration greater than 4, and uncontrolled DM status. According to radiological findings, lesions that were moderately to severely progressed and that involved both sides were more prevalent.
Files
IJPCR,Vol15,Issue5,Article248.pdf
Files
(339.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5dbc0c1fa1d628d47fd94cd8d9f2ae4f
|
339.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-04-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue5,Article248.pdf
- Development Status
- Active
References
- 1. American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40: S11–24. 2. Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K, et al. Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium Tuberculosis. J Clin Med. 2019; 8:2219. 3. Klekotka RB, Mizgała E, Król W. The Etiology of Lower Respiratory Tract Infections in People with Diabetes. Pneumonol Alergol Pol. 2015; 83:401–8. 4. Casqueiro J, Casqueiro J, Alves C. Infections in Patients with Diabetes Mellitus: A Review of Pathogenesis. Indian J Endocr Metab. 2012; 16:27. 5. Hine JL, de Lusignan S, Burleigh D, Pathirannehelage S, McGovern A, Gatenby P, et al. Association Between Glycaemic Control and Common Infections in People with Type 2 Diabetes: A Cohort Study. Diabet Med. 2017; 34:551–7. 6. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 Diabetes and Pneumonia Outcomes. Diabetes Care. 2007; 30: 2251–7. 7. Hsia CCW, Raskin P. The Diabetic Lung: Relevance of Alveolar Microangiopathy for the Use of Inhaled Insulin. Am J Med. 2005; 118:205–11. 8. Vishwakarma P, Usman K, Garg R, Bajpai J, Sethi R, Pradhan A. Clinical and Radiological Presentations of Various Pulmonary Infections in Hospitalized Diabetes Mellitus Patients: A Prospective, Hospital-Based, Comparative, Case Series Study. Pulm Med. 2021; 2021:1–8. 9. Palmar DL. Microbiology of pneumonia in the patients at risk. Am J Med. 1984; 76:53-9. 10. Fekety F, Cladwell J, Gump D, Johnson JE, Maxson W, Mulholland J, et al. Bacteria, viruses and mycoplasma in acute pneumonia in adults. Am Rev Respir Dis. 1977; 104:499-503. 11. Winter Bauer R, Bedon G, Ball W. Recurrent pneumonia predisposing illness and clinical pattern of 158 patients. Ann Intern Med. 1969; 70:689- 92. 12. Levinson M, Kaye D. Pneumonia caused by gram negative bacilli; an overview. Rev Infect Dis. 1985;7: S656-S660. 13. Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, et al. Alveolar Macrophage Dysfunction and Cytokine Storm in the Pathogenesis of Two Severe COVID-19 Patients. E Biomedicine. 2020; 57: 102833. 14. Gombart AF, Pierre A, Maggini S. A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection. Nutrients. 2020; 12:236. 15. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26:510–3. 16. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med. 1994; 96:313–20.17. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1986; 146:2179–85. 18. Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999; 13:349–55. 19. Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P. Diabetes and the risk of urinary tract infection among postmenopausal women. Diabetes Care. 2002; 25:1778–83. 20. Hu KK, Boyko EJ, Scholes D, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004; 164: 989–93. 21. Brown JS, Vittinghof E, Kanaya AM, Agarwal SK, Hulley S, Foxman B. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol. 2001; 98:1045–52. 22. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet JT, Hoepelman AI. Risk factorsforsymptomatic urinary tract infection in women with diabetes mellitus. Diabetes Care. 2000; 23:1737– 41. 23. Wheat LJ: Infections and diabetes mellitus. Diabetes Care:1980; 3:187. 24. Yamagashi F, Suzuki K, Sasaki Y, Saitoh M, Izumizaki M, Koizumi K. Prevalence of coexisting diabetes mellitus among patients with active tuberculosis. Kekkaku. 1996; 71:569-72. 25. Javed F, Shera AS, Memon R, Ansari G. Glucose intolerance in pulmonary tuberculosis. J Pak Med Assoc. 1995; 45: 237-8. 26. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med. 1982; 72(3): 439-50. 27. Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med. 1991; 325(8): 525-32. 28. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg. 1992; 216(2): 172-83. 29. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999; 67(2): 352-60. 30. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19): 1359- 67. 31. Akbar DH, et al. Bacterial pneumonia: comparison between diabetics and nondiabetics. Acta diabetol. 2001; 38:77-82. 32. Jette Kornum B, et al. Type 2 Diabetes and Pneumonia Outcomes. Diabetes Care. 2007; 30:2251-2257. 33. Miquel Falguera, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes. Chest Journal. 2005; 128:3233-3239.